Ageing and multiple sclerosis

JS Graves, KM Krysko, LH Hua, M Absinta… - The Lancet …, 2023 - thelancet.com
The factor that is most relevant and strongly associated with the clinical course of multiple
sclerosis is chronological age. Very young patients exclusively have relapsing remitting …

Social determinants of health in multiple sclerosis

R Dobson, DR Rice, M D'hooghe, R Horne… - Nature Reviews …, 2022 - nature.com
Social determinants of health are the conditions in which people are born, grow, live, work
and age. These circumstances are the non-medical factors that influence health outcomes …

Virtual reality-based therapy improves fatigue, impact, and quality of life in patients with multiple sclerosis. A systematic review with a meta-analysis

I Cortés-Pérez, M Sánchez-Alcalá, FA Nieto-Escámez… - Sensors, 2021 - mdpi.com
Patients with multiple sclerosis (PwMS) have a high level of fatigue and a reduced quality of
life (QoL) due to the impact of multiple sclerosis (MS). Virtual reality-based therapy (VRBT) is …

Sex differences in vitamin D metabolism, serum levels and action

A Wierzbicka, M Oczkowicz - British Journal of Nutrition, 2022 - cambridge.org
The ubiquity of vitamin D metabolising enzymes and vitamin D receptors in mammalian
organisms suggests that vitamin D has pleiotropic effects. There are quite a few studies …

[HTML][HTML] Pregnancy and autoimmune disease: diseases of the nervous system, connective tissue, and the bowel

WM Merz, R Fischer-Betz, K Hellwig… - Deutsches Ärzteblatt …, 2022 - ncbi.nlm.nih.gov
Background Pregnancies in women with chronic disease are on the rise. This pertains to
autoimmune diseases in particular since these tend to affect women of childbearing age …

Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: a cohort study from Germany

T Kümpfel, S Thiel, I Meinl, AI Ciplea… - Neurology …, 2020 - AAN Enterprises
Objective To report pregnancy outcomes and disease activity (DA) in women with MS,
neuromyelitis optica spectrum disorders (NMOSDs), and other neuroimmunologic diseases …

Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society

S Vukusic, C Carra-Dalliere, J Ciron… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Objective: The objective of this study was to develop evidence-based recommendations on
pregnancy management for persons with multiple sclerosis (MS). Background: MS typically …

The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results

S Thiel, AI Ciplea, R Gold… - Therapeutic advances in …, 2021 - journals.sagepub.com
Objectives: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD)
predominantly affect women of reproductive age. During the last few decades many disease …

Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis

Y Kihara, J Chun - Pharmacology & therapeutics, 2023 - Elsevier
Multiple sclerosis (MS) is a neurological, immune-mediated demyelinating disease that
affects people in the prime of life. Environmental, infectious, and genetic factors have been …

Use of disease-modifying drugs during pregnancy and breastfeeding

R Dobson, K Hellwig - Current Opinion in Neurology, 2021 - journals.lww.com
Use of disease-modifying drugs during pregnancy and breastfe... : Current Opinion in
Neurology Use of disease-modifying drugs during pregnancy and breastfeeding : Current …